Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Pain Manag ; 13(5): 271-282, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-37458193

RESUMEN

The aim of this study is to compare the effects of two suspension training (ST) protocols on pain and musculoskeletal function in women with chronic low back pain (CLBP). The study will be randomized, controlled, blinded clinical trial. Women aged 18-60 years who present CLBP will be selected. They will be randomized into three groups: STG1, which will carry out the program with difficulty progression in the exercises; STG2, in which the progression will be made by increasing the number of sets; and control group. STG1 and STG2 will perform the training two-times a week for 60 min for 12 weeks. It is expected that ST will effectively reduce pain and improve functionality in CLBP and that the best protocol will be verified. Clinical Trial Registration: RBR-10rv3fqt.


Low back pain is one of the most common symptoms encountered in everyday life. One of the indicated treatments is the practice of exercises; among them, we can mention the training that uses suspended tapes, called suspension training. The aim of this study is to compare the effects of two suspension training protocols on individuals with chronic low back pain. Methodology: women aged 18 to 60 years with low back pain for more than 12 weeks will be selected. Pre- and post-treatment pain level, trunk and leg motion range and flexibility, functional capacity, biopsychosocial factors, fears and beliefs, pain catastrophizing scale, trunk and leg muscle strength and endurance, depression and anxiety, self-perception and treatment satisfaction will be assessed. The training will take place twice a week, for 60 min, for 3 months. It is expected to verify pain reduction and functionality improvement in both groups and evaluate the best training protocol.


Asunto(s)
Dolor Crónico , Dolor de la Región Lumbar , Adolescente , Adulto , Femenino , Humanos , Persona de Mediana Edad , Dolor Crónico/terapia , Terapia por Ejercicio , Dolor de la Región Lumbar/terapia , Ensayos Clínicos Controlados Aleatorios como Asunto , Resultado del Tratamiento
2.
Lipids ; 55(5): 469-477, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32542681

RESUMEN

Soybean (Glycine max) meal is an important protein source. Soybean meal with lower phytate and oligosaccharides improves meal quality. A single recessive mutation in soybean myo-inositol 1-phosphate synthase (Gm-lpa-TW75-1) confers a seed phenotype with low phytate and increased inorganic phosphate. The mutant was crossed with high oil lines expressing a diacylglycerol acyltransferase1 (DGAT) gene from Vernonia galamensis (VgD). Gm-lpa-TW75-1 X VgD, designated GV, has 21%, and 22% oil and 41% and 43% protein from field and greenhouse seed production, respectively. No significant differences were found in mineral concentrations except for Fe which was 229 µg/g dry mass for GV followed by 174.3 for VgD and 162 for Gm-lpa-TW75-1. Phosphate (Pi) is higher in Gm-lpa-TW75-1 as expected at 5 mg/g, followed by GV at 1.6 mg/g whereas Jack, VgD, and Taiwan75 have about 0.3 mg/g. The Gm-lpa-TW75-1 line has the lowest phytate concentration at 1.4 mg/g followed by GV with 1.8 mg/g compared to Taiwan75, VgD, and Jack with 2.5 mg/g. This work describes a high oil and protein soybean line, GV, with increased Pi and lower phytate which will increase the nutritional value for human and animal feed.


Asunto(s)
Diacilglicerol O-Acetiltransferasa/genética , Glycine max/enzimología , Mio-Inositol-1-Fosfato Sintasa/genética , Plantas Modificadas Genéticamente/genética , Técnicas de Inactivación de Genes , Fosfatos de Inositol/metabolismo , Mutación/genética , Plantas Modificadas Genéticamente/crecimiento & desarrollo , Semillas/genética , Semillas/crecimiento & desarrollo , Glycine max/genética , Glycine max/crecimiento & desarrollo , Vernonia/enzimología , Vernonia/genética
3.
Medicine (Baltimore) ; 94(37): e1508, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26376395

RESUMEN

Hereditary pancreatitis (HP) is an autosomal-dominant disease with incomplete penetrance manifesting as early-onset chronic relapsing pancreatitis. A mutation in the PRSS1 gene is present in greater than 70% of HP kindreds and leads to a gain-of-function characterized by the increased autocatalytic conversion of trypsinogen to active trypsin, promoting autodigestion and damage to acinar cells. Other genetic defects observed in the pathogenic mechanism of pancreatitis include mutations in the genes encoding SPINK1, CTRC, and CPA1. There are few reports of HP in Latin America, and no families have been investigated in Brazil. A case-control observational study was conducted at Clementino Fraga Filho University Hospital in Brazil. Patients with suspected HP and healthy controls were enrolled in this study, and a detailed questionnaire was administered to patients with HP. PRSS1 and SPINK1 genes were analyzed by DNA sequencing, and a family that fit the HP diagnostic criteria was identified. The neutral polymorphism c.88-352A > G in the SPINK1 gene was found to be prevalent in the individuals studied, but no important alterations were found in this gene. Ten out of 16 individuals in this family carried the N29T mutation in the PRSS1 gene, with 2 clinically unaffected mutation carriers. The median age of HP onset was 6 years. Pancreatic exocrine failure occurred in 6 patients, 5 of whom also had diabetes mellitus. Surgical procedures were performed on 3 affected members, and no cases of pancreatic cancer have been reported thus far. This study identified the first PRSS1 gene mutation in a Brazilian family with HP.


Asunto(s)
Proteínas Portadoras/genética , Pancreatitis/genética , Tripsina/genética , Adolescente , Estudios de Casos y Controles , Niño , Preescolar , Humanos , Mutación Missense , Inhibidor de Tripsina Pancreática de Kazal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA